The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase I trial combining pembrolizumab and doxorubicin in patients with metastatic triple negative breast cancer.
 
Yuan Yuan
Consulting or Advisory Role - BCI Pharma; Diiachi; Eisai; Genentech; Guardant Health; Immunomedics; Novartis; Pfizer
Speakers' Bureau - AstraZeneca; Daiichi Sankyo/Lilly; Eisai; Genentech
Research Funding - Genentech; Imugene; Merck; Novartis; Pfizer
Expert Testimony - Novartis
 
Xuan Ge
No Relationships to Disclose
 
Susan Elaine Yost
No Relationships to Disclose
 
Jin Sun Lee
No Relationships to Disclose
 
Paul Henry Frankel
Stock and Other Ownership Interests - Asensus Surgical; Geron
Consulting or Advisory Role - Johnson & Johnson/Janssen
Other Relationship - FlexSim
 
Christopher Ruel
No Relationships to Disclose
 
Yujie Cui
No Relationships to Disclose
 
Mireya Murga
No Relationships to Disclose
 
Aileen Tang
No Relationships to Disclose
 
Norma Martinez
No Relationships to Disclose
 
Misagh Karimi
Honoraria - AstraZeneca; Bristol-Myers Squibb; GlaxoSmithKline; Merck; Seattle Genetics/Astellas
Consulting or Advisory Role - GlaxoSmithKline
Speakers' Bureau - Bristol-Myers Squibb; Genentech; Merck
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
George Somlo
No Relationships to Disclose
 
Joanne E. Mortimer
Consulting or Advisory Role - GlaxoSmithKline; Novartis; Pfizer; Puma Biotechnology
 
James Ross Waisman
No Relationships to Disclose